Inventor · New York, NY, US

Mark Pruzanski

15Patents
5h-index
16Co-inventors
59Inventor score

Filing activity: Mar 14, 2005 → Mar 21, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US9763964B2 Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Chemistry; Metallurgy 19 Active
US10052337B2 Compositions of obeticholic acid and methods of use Chemistry; Metallurgy 16 Active
US7858608B2 Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Chemistry; Metallurgy 13 Active
US7932244B2 Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Chemistry; Metallurgy 12 Active
US9498484B2 Treatment of fibrosis using FXR ligands Human Necessities 7 Active
US8546365B2 Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Chemistry; Metallurgy 4 Active
US10894054B2 FXR agonist compositions for combination therapy Chemistry; Metallurgy 2 Active
US9090652B2 Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions Chemistry; Metallurgy 2 Active
US11311557B2 Pharmaceutical compositions for combination therapy Human Necessities 1 Active
US10758549B2 Compositions of obeticholic acid and methods of use Chemistry; Metallurgy 1 Active
US10646499B2 Compositions of obeticholic acid and methods of use Chemistry; Metallurgy 0 Active
US12337003B2 Pharmaceutical compositions for combination therapy Human Necessities 0 Active
US10258633B2 Treatment of fibrosis using FXR ligands Human Necessities 0 Active
US10751349B2 Compositions of obeticholic acid and methods of use Chemistry; Metallurgy 0 Active
US10987362B2 Treatment of fibrosis using FXR ligands Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.